 David Orlicky
Concepts (904)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 47 | 2023 | 1637 | 2.310 |
Why?
| | Cholestasis | 12 | 2023 | 225 | 1.740 |
Why?
| | Mice | 118 | 2023 | 14872 | 1.570 |
Why?
| | Pelvic Organ Prolapse | 3 | 2023 | 39 | 1.560 |
Why?
| | Non-alcoholic Fatty Liver Disease | 10 | 2022 | 245 | 1.540 |
Why?
| | Ethanol | 19 | 2023 | 538 | 1.510 |
Why?
| | Lipid Metabolism | 18 | 2020 | 444 | 1.500 |
Why?
| | Animals | 166 | 2023 | 31709 | 1.370 |
Why?
| | Hepatocytes | 9 | 2023 | 195 | 1.350 |
Why?
| | Liver Diseases, Alcoholic | 10 | 2022 | 81 | 1.260 |
Why?
| | Perilipin-2 | 13 | 2019 | 36 | 1.240 |
Why?
| | Mice, Inbred C57BL | 55 | 2023 | 4694 | 1.220 |
Why?
| | Ligaments | 3 | 2023 | 45 | 1.050 |
Why?
| | Oxidative Stress | 23 | 2022 | 1076 | 1.030 |
Why?
| | Receptors, Prostaglandin | 13 | 1998 | 22 | 0.990 |
Why?
| | Obesity | 15 | 2023 | 2508 | 0.980 |
Why?
| | Fatty Liver | 12 | 2021 | 211 | 0.960 |
Why?
| | Mice, Knockout | 35 | 2023 | 2570 | 0.920 |
Why?
| | Dinoprost | 15 | 1996 | 31 | 0.900 |
Why?
| | Acetaminophen | 6 | 2022 | 241 | 0.860 |
Why?
| | Metabolic Syndrome | 7 | 2023 | 321 | 0.850 |
Why?
| | Fatty Liver, Alcoholic | 5 | 2021 | 14 | 0.840 |
Why?
| | Uterus | 4 | 2020 | 192 | 0.820 |
Why?
| | Bile Acids and Salts | 9 | 2023 | 171 | 0.770 |
Why?
| | Adipocytes | 6 | 2018 | 188 | 0.740 |
Why?
| | Fructose | 9 | 2023 | 100 | 0.740 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2017 | 102 | 0.720 |
Why?
| | Fructokinases | 8 | 2023 | 29 | 0.720 |
Why?
| | Receptors, Estrogen | 2 | 2023 | 372 | 0.720 |
Why?
| | Cytoplasm | 6 | 2016 | 255 | 0.700 |
Why?
| | Sacrum | 1 | 2020 | 65 | 0.690 |
Why?
| | Disease Models, Animal | 30 | 2023 | 3535 | 0.680 |
Why?
| | Aldehydes | 10 | 2022 | 138 | 0.670 |
Why?
| | Protein Carbonylation | 8 | 2018 | 51 | 0.670 |
Why?
| | Milk | 7 | 2019 | 124 | 0.650 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 11 | 0.640 |
Why?
| | Dietary Fats | 5 | 2022 | 287 | 0.610 |
Why?
| | Skin | 9 | 2019 | 655 | 0.600 |
Why?
| | Liver Diseases | 5 | 2023 | 255 | 0.590 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 4 | 2021 | 192 | 0.590 |
Why?
| | Chemical Warfare Agents | 6 | 2014 | 119 | 0.590 |
Why?
| | Kidney | 8 | 2019 | 1188 | 0.590 |
Why?
| | Chemical and Drug Induced Liver Injury | 5 | 2022 | 125 | 0.580 |
Why?
| | NF-kappa B | 6 | 2023 | 641 | 0.570 |
Why?
| | Antioxidants | 10 | 2023 | 530 | 0.560 |
Why?
| | Neoplasm Proteins | 9 | 2005 | 385 | 0.560 |
Why?
| | Mechlorethamine | 5 | 2015 | 63 | 0.560 |
Why?
| | Membrane Proteins | 12 | 2016 | 1019 | 0.550 |
Why?
| | Lactation | 10 | 2019 | 149 | 0.550 |
Why?
| | Diet, High-Fat | 9 | 2020 | 225 | 0.520 |
Why?
| | Mammary Glands, Animal | 7 | 2019 | 117 | 0.520 |
Why?
| | Organelles | 2 | 2013 | 51 | 0.510 |
Why?
| | Cholangitis, Sclerosing | 3 | 2023 | 66 | 0.500 |
Why?
| | Parenteral Nutrition | 5 | 2023 | 96 | 0.500 |
Why?
| | Glutathione Transferase | 6 | 2019 | 93 | 0.500 |
Why?
| | Mitochondria | 6 | 2019 | 747 | 0.490 |
Why?
| | PTEN Phosphohydrolase | 4 | 2018 | 140 | 0.470 |
Why?
| | Ovary | 4 | 2022 | 191 | 0.460 |
Why?
| | Male | 67 | 2023 | 55609 | 0.440 |
Why?
| | Inflammation | 16 | 2023 | 2480 | 0.440 |
Why?
| | Alcohol Drinking | 4 | 2016 | 651 | 0.440 |
Why?
| | DNA Damage | 7 | 2021 | 351 | 0.430 |
Why?
| | Prostaglandins F | 6 | 1988 | 17 | 0.420 |
Why?
| | Peptides | 3 | 2008 | 848 | 0.410 |
Why?
| | Down Syndrome | 3 | 2023 | 335 | 0.400 |
Why?
| | Alcoholic Intoxication | 2 | 2023 | 62 | 0.390 |
Why?
| | Receptors, Virus | 2 | 2003 | 75 | 0.390 |
Why?
| | Superoxide Dismutase | 6 | 2019 | 306 | 0.390 |
Why?
| | Fructose Intolerance | 2 | 2023 | 3 | 0.380 |
Why?
| | Transfection | 8 | 2016 | 866 | 0.380 |
Why?
| | Adenoviridae | 2 | 2003 | 184 | 0.370 |
Why?
| | Mustard Gas | 5 | 2014 | 117 | 0.360 |
Why?
| | Thioredoxin Reductase 1 | 3 | 2023 | 8 | 0.360 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 284 | 0.360 |
Why?
| | Energy Metabolism | 5 | 2019 | 731 | 0.350 |
Why?
| | Lens, Crystalline | 2 | 2022 | 90 | 0.350 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2017 | 160 | 0.350 |
Why?
| | Endometrium | 6 | 1988 | 60 | 0.350 |
Why?
| | Burns | 2 | 2023 | 237 | 0.340 |
Why?
| | Carcinoma, Hepatocellular | 2 | 2023 | 211 | 0.340 |
Why?
| | Glutathione Reductase | 3 | 2019 | 21 | 0.340 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 25 | 0.340 |
Why?
| | Precancerous Conditions | 2 | 2023 | 158 | 0.340 |
Why?
| | Carcinoma, Basal Cell | 2 | 2022 | 68 | 0.330 |
Why?
| | Signal Transduction | 14 | 2022 | 4516 | 0.330 |
Why?
| | Thioredoxins | 3 | 2018 | 33 | 0.330 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2014 | 172 | 0.330 |
Why?
| | Lipids | 7 | 2019 | 580 | 0.320 |
Why?
| | Female | 55 | 2023 | 59523 | 0.320 |
Why?
| | Rats | 18 | 2022 | 4958 | 0.320 |
Why?
| | Lung Injury | 2 | 2021 | 198 | 0.310 |
Why?
| | Immunity, Innate | 5 | 2023 | 720 | 0.310 |
Why?
| | Ultraviolet Rays | 4 | 2022 | 363 | 0.310 |
Why?
| | Fallopian Tubes | 2 | 2022 | 29 | 0.310 |
Why?
| | Taste | 2 | 2021 | 208 | 0.310 |
Why?
| | Colitis | 2 | 2021 | 223 | 0.310 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2021 | 270 | 0.310 |
Why?
| | Sevelamer | 2 | 2020 | 9 | 0.310 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2320 | 0.310 |
Why?
| | Humans | 63 | 2023 | 114709 | 0.310 |
Why?
| | Skin Neoplasms | 3 | 2022 | 756 | 0.300 |
Why?
| | Leptin | 2 | 2020 | 210 | 0.290 |
Why?
| | Macrophages | 6 | 2021 | 1263 | 0.290 |
Why?
| | Lung | 7 | 2022 | 3561 | 0.290 |
Why?
| | Hibernation | 2 | 2023 | 72 | 0.290 |
Why?
| | Liver Neoplasms | 2 | 2023 | 506 | 0.290 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 22 | 0.290 |
Why?
| | Epithelial Cells | 7 | 2022 | 951 | 0.280 |
Why?
| | Kidney Diseases | 2 | 2023 | 350 | 0.280 |
Why?
| | RNA, Messenger | 12 | 2023 | 2553 | 0.280 |
Why?
| | Genetic Vectors | 4 | 2010 | 289 | 0.280 |
Why?
| | Lipid Peroxidation | 5 | 2014 | 139 | 0.280 |
Why?
| | Triglycerides | 8 | 2021 | 467 | 0.270 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 398 | 0.260 |
Why?
| | Lipid Droplets | 4 | 2019 | 21 | 0.260 |
Why?
| | HEK293 Cells | 5 | 2021 | 591 | 0.260 |
Why?
| | Blister | 4 | 2014 | 43 | 0.260 |
Why?
| | Mice, Hairless | 9 | 2017 | 74 | 0.260 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 211 | 0.260 |
Why?
| | Irritants | 2 | 2017 | 41 | 0.250 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2022 | 486 | 0.250 |
Why?
| | Diet, Western | 3 | 2022 | 66 | 0.250 |
Why?
| | Glycoproteins | 4 | 2021 | 304 | 0.250 |
Why?
| | Pancreatic Neoplasms | 4 | 2020 | 731 | 0.250 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2010 | 29 | 0.250 |
Why?
| | Endoplasmic Reticulum | 5 | 2019 | 234 | 0.250 |
Why?
| | Transduction, Genetic | 3 | 2003 | 113 | 0.240 |
Why?
| | Liver Cirrhosis | 5 | 2023 | 227 | 0.240 |
Why?
| | Dioxanes | 2 | 2021 | 5 | 0.240 |
Why?
| | Colon | 3 | 2023 | 233 | 0.240 |
Why?
| | Immunohistochemistry | 12 | 2018 | 1629 | 0.240 |
Why?
| | Glycine | 2 | 2016 | 152 | 0.240 |
Why?
| | Oxygen | 3 | 2018 | 854 | 0.230 |
Why?
| | Cell Line | 14 | 2022 | 2637 | 0.230 |
Why?
| | Protein Processing, Post-Translational | 4 | 2017 | 399 | 0.230 |
Why?
| | Silymarin | 2 | 2016 | 194 | 0.230 |
Why?
| | Dietary Sucrose | 2 | 2023 | 45 | 0.230 |
Why?
| | Tumor Necrosis Factor-alpha | 4 | 2023 | 1140 | 0.220 |
Why?
| | Gene Deletion | 4 | 2018 | 356 | 0.220 |
Why?
| | Glycolipids | 2 | 2016 | 35 | 0.220 |
Why?
| | Glutathione | 7 | 2021 | 293 | 0.220 |
Why?
| | Lipoproteins | 2 | 2021 | 159 | 0.220 |
Why?
| | Proteomics | 5 | 2021 | 836 | 0.220 |
Why?
| | Digestive System Diseases | 1 | 2023 | 23 | 0.220 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 219 | 0.220 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2018 | 577 | 0.220 |
Why?
| | Autophagy | 3 | 2022 | 235 | 0.220 |
Why?
| | Azotemia | 1 | 2023 | 6 | 0.220 |
Why?
| | High Fructose Corn Syrup | 1 | 2023 | 7 | 0.220 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 155 | 0.210 |
Why?
| | Patched-1 Receptor | 2 | 2022 | 15 | 0.210 |
Why?
| | Estrogen Receptor beta | 1 | 2023 | 35 | 0.210 |
Why?
| | Alprostadil | 4 | 1992 | 32 | 0.210 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 234 | 0.210 |
Why?
| | Torpor | 1 | 2023 | 14 | 0.210 |
Why?
| | Corpus Luteum | 4 | 1992 | 19 | 0.210 |
Why?
| | Alcoholism | 2 | 2022 | 713 | 0.210 |
Why?
| | Cell Membrane | 5 | 2016 | 680 | 0.210 |
Why?
| | Weight Gain | 4 | 2019 | 453 | 0.210 |
Why?
| | Antidotes | 2 | 2015 | 135 | 0.210 |
Why?
| | Mast Cells | 4 | 2019 | 116 | 0.210 |
Why?
| | Membrane Glycoproteins | 4 | 2021 | 430 | 0.210 |
Why?
| | Phospholipids | 2 | 2017 | 197 | 0.210 |
Why?
| | Catalase | 3 | 2017 | 118 | 0.210 |
Why?
| | Cell Proliferation | 11 | 2020 | 2187 | 0.210 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 378 | 0.210 |
Why?
| | Proteins | 6 | 2013 | 908 | 0.210 |
Why?
| | Dermatitis, Contact | 2 | 2013 | 23 | 0.200 |
Why?
| | Nucleotides | 2 | 2021 | 112 | 0.200 |
Why?
| | Phosphorylation | 6 | 2020 | 1569 | 0.200 |
Why?
| | Estrogen Receptor alpha | 1 | 2023 | 121 | 0.200 |
Why?
| | Endotoxemia | 1 | 2023 | 86 | 0.200 |
Why?
| | Abdominal Injuries | 1 | 2023 | 108 | 0.200 |
Why?
| | Receptors, Androgen | 1 | 2023 | 131 | 0.200 |
Why?
| | Thermogenesis | 2 | 2019 | 37 | 0.200 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 38 | 0.200 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 13 | 0.190 |
Why?
| | Energy Intake | 3 | 2021 | 427 | 0.190 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 215 | 0.190 |
Why?
| | Blotting, Western | 9 | 2015 | 1147 | 0.190 |
Why?
| | Estrogens | 2 | 2023 | 312 | 0.190 |
Why?
| | Isoxazoles | 1 | 2021 | 51 | 0.190 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 343 | 0.190 |
Why?
| | Biomarkers | 7 | 2023 | 3408 | 0.190 |
Why?
| | Glucose | 4 | 2023 | 897 | 0.190 |
Why?
| | Bacterial Toxins | 1 | 2022 | 103 | 0.190 |
Why?
| | Phytosterols | 1 | 2021 | 11 | 0.190 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 43 | 0.190 |
Why?
| | Apoptosis | 10 | 2020 | 2363 | 0.190 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 82 | 0.190 |
Why?
| | Biomarkers, Tumor | 3 | 2016 | 1040 | 0.190 |
Why?
| | Drug Resistance | 1 | 2022 | 158 | 0.190 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 91 | 0.190 |
Why?
| | Tandem Mass Spectrometry | 6 | 2022 | 412 | 0.190 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 71 | 0.180 |
Why?
| | Adrenal Glands | 1 | 2021 | 66 | 0.180 |
Why?
| | Fatty Acids | 4 | 2022 | 381 | 0.180 |
Why?
| | Eye | 1 | 2022 | 98 | 0.180 |
Why?
| | Peroxiredoxins | 2 | 2018 | 23 | 0.180 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2022 | 194 | 0.180 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 18 | 0.180 |
Why?
| | 3T3 Cells | 4 | 2003 | 140 | 0.180 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 23 | 0.180 |
Why?
| | Hepatitis | 2 | 2019 | 45 | 0.180 |
Why?
| | Quinolines | 1 | 2022 | 129 | 0.180 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 31 | 0.180 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.180 |
Why?
| | Azetidines | 1 | 2020 | 31 | 0.180 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 54 | 0.180 |
Why?
| | Vasopressins | 1 | 2021 | 56 | 0.180 |
Why?
| | Momordica charantia | 1 | 2020 | 13 | 0.180 |
Why?
| | Kidney Tubules | 2 | 2019 | 107 | 0.180 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 31 | 0.180 |
Why?
| | Uric Acid | 1 | 2021 | 148 | 0.180 |
Why?
| | Microtubule-Associated Proteins | 4 | 2019 | 174 | 0.180 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 15 | 0.180 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 308 | 0.170 |
Why?
| | Case-Control Studies | 4 | 2020 | 3004 | 0.170 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2022 | 194 | 0.170 |
Why?
| | Carcinogens | 2 | 2013 | 103 | 0.170 |
Why?
| | Sugars | 1 | 2020 | 29 | 0.170 |
Why?
| | Protein Biosynthesis | 3 | 2001 | 387 | 0.170 |
Why?
| | Monocytes | 2 | 2021 | 504 | 0.170 |
Why?
| | Gene Expression | 2 | 2023 | 1421 | 0.170 |
Why?
| | Melanocytes | 1 | 2020 | 55 | 0.170 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 128 | 0.170 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 54 | 0.170 |
Why?
| | Adipose Tissue | 3 | 2019 | 545 | 0.170 |
Why?
| | Herpesviridae Infections | 1 | 2021 | 138 | 0.170 |
Why?
| | Myometrium | 1 | 2020 | 35 | 0.170 |
Why?
| | PPAR alpha | 3 | 2016 | 52 | 0.170 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1143 | 0.170 |
Why?
| | Up-Regulation | 6 | 2022 | 808 | 0.170 |
Why?
| | Cholesterol | 5 | 2022 | 367 | 0.170 |
Why?
| | Sucrose | 3 | 2018 | 92 | 0.170 |
Why?
| | Intestines | 3 | 2020 | 326 | 0.170 |
Why?
| | Deoxycytidine | 1 | 2020 | 138 | 0.170 |
Why?
| | SNARE Proteins | 1 | 2019 | 37 | 0.170 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 168 | 0.170 |
Why?
| | Cytokines | 5 | 2022 | 1841 | 0.170 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 35 | 0.170 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 25 | 0.160 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2021 | 25 | 0.160 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2020 | 445 | 0.160 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 15 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 801 | 0.160 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 15 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 498 | 0.160 |
Why?
| | Ileum | 1 | 2019 | 90 | 0.160 |
Why?
| | Acylation | 1 | 2019 | 28 | 0.160 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 164 | 0.160 |
Why?
| | Models, Animal | 2 | 2022 | 344 | 0.160 |
Why?
| | Kupffer Cells | 1 | 2019 | 45 | 0.160 |
Why?
| | Leishmania major | 1 | 2018 | 6 | 0.160 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 7 | 0.160 |
Why?
| | Emphysema | 1 | 2019 | 107 | 0.160 |
Why?
| | Plant Extracts | 1 | 2020 | 154 | 0.160 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 75 | 0.160 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 264 | 0.160 |
Why?
| | Adenocarcinoma | 3 | 2011 | 795 | 0.160 |
Why?
| | Phenotype | 3 | 2023 | 2797 | 0.160 |
Why?
| | Nitric Oxide | 3 | 2020 | 823 | 0.150 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2019 | 181 | 0.150 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2022 | 2096 | 0.150 |
Why?
| | Altitude Sickness | 1 | 2020 | 172 | 0.150 |
Why?
| | Nanoparticles | 1 | 2022 | 313 | 0.150 |
Why?
| | Intestine, Small | 2 | 2020 | 122 | 0.150 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 14 | 0.150 |
Why?
| | Arteries | 1 | 2020 | 247 | 0.150 |
Why?
| | Cold Temperature | 1 | 2019 | 126 | 0.150 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 48 | 0.150 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 27 | 0.150 |
Why?
| | Endothelial Cells | 1 | 2023 | 687 | 0.150 |
Why?
| | Protein Kinases | 1 | 2020 | 307 | 0.150 |
Why?
| | Pneumonia | 1 | 2023 | 568 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 68 | 0.150 |
Why?
| | Oxidation-Reduction | 5 | 2021 | 923 | 0.150 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 98 | 0.150 |
Why?
| | Hep G2 Cells | 4 | 2021 | 60 | 0.150 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 30 | 0.150 |
Why?
| | Insulin Resistance | 4 | 2019 | 1072 | 0.150 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 3 | 0.150 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 247 | 0.150 |
Why?
| | Glucosides | 1 | 2018 | 36 | 0.150 |
Why?
| | Base Sequence | 6 | 2015 | 2114 | 0.150 |
Why?
| | Relaxin | 1 | 2017 | 15 | 0.150 |
Why?
| | Intestinal Mucosa | 3 | 2016 | 532 | 0.140 |
Why?
| | Proteome | 2 | 2019 | 339 | 0.140 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 33 | 0.140 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 60 | 0.140 |
Why?
| | Transcription, Genetic | 3 | 2005 | 1313 | 0.140 |
Why?
| | Virulence Factors | 1 | 2018 | 139 | 0.140 |
Why?
| | Sulfonamides | 1 | 2020 | 445 | 0.140 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.140 |
Why?
| | Hypersensitivity | 1 | 2020 | 252 | 0.140 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 531 | 0.140 |
Why?
| | Vasodilation | 1 | 2020 | 419 | 0.140 |
Why?
| | Disease Progression | 6 | 2020 | 2381 | 0.140 |
Why?
| | Phosgene | 1 | 2017 | 6 | 0.140 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 93 | 0.140 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.140 |
Why?
| | Oximes | 1 | 2017 | 19 | 0.140 |
Why?
| | Temperature | 2 | 2018 | 565 | 0.140 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2022 | 14 | 0.140 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 238 | 0.140 |
Why?
| | Cytochrome b Group | 1 | 2016 | 16 | 0.140 |
Why?
| | Metabolic Diseases | 1 | 2018 | 98 | 0.140 |
Why?
| | Cell Differentiation | 7 | 2020 | 1701 | 0.140 |
Why?
| | Spleen | 2 | 2018 | 487 | 0.140 |
Why?
| | Acute Kidney Injury | 1 | 2023 | 638 | 0.140 |
Why?
| | DNA Primers | 5 | 2015 | 510 | 0.140 |
Why?
| | Sciuridae | 2 | 2023 | 142 | 0.140 |
Why?
| | Amino Acid Sequence | 6 | 2020 | 1982 | 0.140 |
Why?
| | Nephrosclerosis | 1 | 2016 | 6 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 671 | 0.140 |
Why?
| | Apocrine Glands | 1 | 2016 | 4 | 0.140 |
Why?
| | Cells, Cultured | 10 | 2020 | 3886 | 0.140 |
Why?
| | Zebrafish | 1 | 2020 | 412 | 0.130 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 25 | 0.130 |
Why?
| | Necrosis | 2 | 2015 | 211 | 0.130 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 141 | 0.130 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 63 | 0.130 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 9 | 0.130 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 45 | 0.130 |
Why?
| | Metalloporphyrins | 2 | 2014 | 103 | 0.130 |
Why?
| | Mice, Obese | 3 | 2023 | 53 | 0.130 |
Why?
| | Homocystinuria | 1 | 2017 | 62 | 0.130 |
Why?
| | Salmonella enterica | 1 | 2016 | 49 | 0.130 |
Why?
| | Choline | 1 | 2017 | 106 | 0.130 |
Why?
| | Rabbits | 10 | 2002 | 733 | 0.130 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 638 | 0.130 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2540 | 0.130 |
Why?
| | Estradiol | 4 | 1988 | 455 | 0.130 |
Why?
| | Disease Susceptibility | 2 | 2020 | 316 | 0.130 |
Why?
| | Microbiota | 1 | 2023 | 647 | 0.130 |
Why?
| | Optical Imaging | 1 | 2016 | 54 | 0.130 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2177 | 0.130 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 1996 | 67 | 0.130 |
Why?
| | Biliary Atresia | 1 | 2018 | 185 | 0.130 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1230 | 0.130 |
Why?
| | Fibrosis | 4 | 2022 | 453 | 0.130 |
Why?
| | Acetylcysteine | 2 | 2022 | 141 | 0.130 |
Why?
| | Epithelium, Corneal | 1 | 2016 | 35 | 0.130 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 17 | 0.130 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 796 | 0.130 |
Why?
| | Lysine | 1 | 2017 | 242 | 0.130 |
Why?
| | Peroxidase | 5 | 2015 | 163 | 0.130 |
Why?
| | MicroRNAs | 1 | 2021 | 600 | 0.130 |
Why?
| | Cell Division | 7 | 1988 | 758 | 0.120 |
Why?
| | Epidermis | 2 | 2014 | 149 | 0.120 |
Why?
| | Mice, Transgenic | 5 | 2021 | 1950 | 0.120 |
Why?
| | Down-Regulation | 4 | 2022 | 594 | 0.120 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 122 | 0.120 |
Why?
| | Pelvis | 1 | 2016 | 90 | 0.120 |
Why?
| | Skin Diseases | 1 | 2017 | 122 | 0.120 |
Why?
| | Diet | 3 | 2018 | 1080 | 0.120 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 468 | 0.120 |
Why?
| | Chemokines | 3 | 2023 | 216 | 0.120 |
Why?
| | Space Flight | 1 | 2016 | 127 | 0.120 |
Why?
| | Carcinogenesis | 3 | 2023 | 177 | 0.120 |
Why?
| | Molecular Sequence Data | 6 | 2015 | 2785 | 0.120 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 785 | 0.120 |
Why?
| | Hematopoietic System | 1 | 2014 | 8 | 0.120 |
Why?
| | Interleukin-6 | 3 | 2023 | 676 | 0.120 |
Why?
| | Cytoprotection | 2 | 2015 | 51 | 0.120 |
Why?
| | Breast Feeding | 1 | 2018 | 368 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 396 | 0.120 |
Why?
| | Alanine Transaminase | 4 | 2016 | 142 | 0.120 |
Why?
| | Vagina | 1 | 2016 | 146 | 0.120 |
Why?
| | Body Weight | 5 | 2016 | 869 | 0.120 |
Why?
| | Weight Loss | 1 | 2019 | 642 | 0.120 |
Why?
| | Motor Activity | 1 | 2019 | 640 | 0.120 |
Why?
| | Mice, Inbred ICR | 3 | 2021 | 109 | 0.110 |
Why?
| | Middle Aged | 9 | 2020 | 26738 | 0.110 |
Why?
| | Melanoma | 1 | 2020 | 620 | 0.110 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 20 | 0.110 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 8 | 0.110 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 615 | 0.110 |
Why?
| | Dermis | 1 | 2014 | 30 | 0.110 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 39 | 0.110 |
Why?
| | Cloning, Molecular | 4 | 2010 | 522 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 219 | 0.110 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 20 | 0.110 |
Why?
| | Stilbenes | 1 | 2013 | 36 | 0.110 |
Why?
| | Methylation | 1 | 2014 | 208 | 0.110 |
Why?
| | Heart | 1 | 2017 | 612 | 0.110 |
Why?
| | Macrophage Activation | 3 | 2023 | 164 | 0.110 |
Why?
| | Metabolomics | 4 | 2022 | 521 | 0.110 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 113 | 0.110 |
Why?
| | Phosphoproteins | 2 | 2013 | 298 | 0.110 |
Why?
| | Grape Seed Extract | 1 | 2013 | 41 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2018 | 766 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 2 | 2020 | 501 | 0.110 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 133 | 0.110 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1996 | 153 | 0.110 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 347 | 0.110 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 67 | 0.110 |
Why?
| | Organ Size | 4 | 2016 | 436 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 447 | 0.110 |
Why?
| | Isoproterenol | 1 | 2013 | 106 | 0.110 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 325 | 0.110 |
Why?
| | Lymphopenia | 1 | 2013 | 49 | 0.100 |
Why?
| | Inositol Phosphates | 3 | 1988 | 23 | 0.100 |
Why?
| | Green Fluorescent Proteins | 3 | 2011 | 371 | 0.100 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2013 | 60 | 0.100 |
Why?
| | Mothers | 2 | 2018 | 651 | 0.100 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 7 | 0.100 |
Why?
| | Microfilament Proteins | 1 | 2013 | 126 | 0.100 |
Why?
| | Myocardium | 1 | 2017 | 913 | 0.100 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 63 | 0.100 |
Why?
| | Testis | 1 | 1992 | 133 | 0.100 |
Why?
| | Carrier Proteins | 3 | 2017 | 695 | 0.100 |
Why?
| | Cattle | 6 | 2016 | 920 | 0.100 |
Why?
| | Perilipin-3 | 2 | 2008 | 2 | 0.100 |
Why?
| | Neurons | 1 | 2019 | 1280 | 0.100 |
Why?
| | Mammals | 2 | 2023 | 244 | 0.100 |
Why?
| | DNA, Complementary | 3 | 2016 | 256 | 0.090 |
Why?
| | Arousal | 1 | 2012 | 152 | 0.090 |
Why?
| | Fructose-Bisphosphate Aldolase | 2 | 2023 | 7 | 0.090 |
Why?
| | Eye Proteins | 2 | 2021 | 70 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Taurine | 1 | 2011 | 41 | 0.090 |
Why?
| | Administration, Cutaneous | 3 | 2017 | 117 | 0.090 |
Why?
| | Mutation | 3 | 2020 | 3346 | 0.090 |
Why?
| | Ligands | 2 | 2023 | 562 | 0.090 |
Why?
| | Nasal Cavity | 1 | 2011 | 47 | 0.090 |
Why?
| | Microtubules | 1 | 2013 | 237 | 0.090 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 60 | 0.090 |
Why?
| | Cohort Studies | 1 | 2020 | 4895 | 0.090 |
Why?
| | Acetaldehyde | 1 | 2010 | 15 | 0.090 |
Why?
| | Blood Proteins | 1 | 2012 | 231 | 0.090 |
Why?
| | Chenodeoxycholic Acid | 2 | 2021 | 12 | 0.090 |
Why?
| | Luminescent Proteins | 2 | 2001 | 166 | 0.090 |
Why?
| | Glycolysis | 2 | 2021 | 227 | 0.090 |
Why?
| | Heme Oxygenase-1 | 2 | 2021 | 52 | 0.090 |
Why?
| | Pregnancy | 6 | 2020 | 5520 | 0.090 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1144 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 923 | 0.080 |
Why?
| | Multidrug Resistance-Associated Proteins | 2 | 2021 | 34 | 0.080 |
Why?
| | Casein Kinase II | 1 | 2009 | 21 | 0.080 |
Why?
| | COS Cells | 2 | 2003 | 175 | 0.080 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 616 | 0.080 |
Why?
| | Protein Folding | 1 | 2011 | 239 | 0.080 |
Why?
| | Hypertension | 1 | 2017 | 1056 | 0.080 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 52 | 0.080 |
Why?
| | Prospective Studies | 1 | 2020 | 6220 | 0.080 |
Why?
| | Peroxiredoxin VI | 1 | 2009 | 5 | 0.080 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 90 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 4 | 2016 | 2218 | 0.080 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 73 | 0.080 |
Why?
| | Lysosomes | 2 | 2019 | 123 | 0.080 |
Why?
| | Serine | 1 | 2009 | 126 | 0.080 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 26 | 0.080 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 45 | 0.080 |
Why?
| | Organ Specificity | 3 | 2018 | 268 | 0.080 |
Why?
| | Oleic Acid | 1 | 2008 | 30 | 0.080 |
Why?
| | Exosomes | 1 | 2009 | 92 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2008 | 95 | 0.080 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2019 | 91 | 0.080 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 502 | 0.080 |
Why?
| | Kidney Function Tests | 2 | 2019 | 140 | 0.070 |
Why?
| | Tissue Distribution | 3 | 2007 | 286 | 0.070 |
Why?
| | Adiposity | 2 | 2015 | 458 | 0.070 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 282 | 0.070 |
Why?
| | Adult | 9 | 2020 | 30554 | 0.070 |
Why?
| | Risk Factors | 1 | 2020 | 8634 | 0.070 |
Why?
| | Muscle, Smooth | 2 | 2019 | 144 | 0.070 |
Why?
| | Vasotocin | 1 | 2006 | 5 | 0.070 |
Why?
| | Affinity Labels | 3 | 1992 | 25 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 32 | 0.070 |
Why?
| | Urethane | 1 | 2007 | 41 | 0.070 |
Why?
| | Muscle Tonus | 1 | 2006 | 17 | 0.070 |
Why?
| | Neoplasm Invasiveness | 2 | 2020 | 442 | 0.070 |
Why?
| | Lipogenesis | 2 | 2018 | 56 | 0.070 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 850 | 0.070 |
Why?
| | Uterine Contraction | 1 | 2006 | 17 | 0.070 |
Why?
| | Prostaglandins | 1 | 2006 | 77 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 630 | 0.070 |
Why?
| | Sugar Phosphates | 1 | 1986 | 2 | 0.070 |
Why?
| | Lizards | 1 | 2006 | 34 | 0.070 |
Why?
| | Azides | 3 | 1992 | 46 | 0.070 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2014 | 157 | 0.070 |
Why?
| | Thermodynamics | 1 | 2008 | 382 | 0.070 |
Why?
| | Acetylation | 2 | 2017 | 211 | 0.060 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 388 | 0.060 |
Why?
| | Amidinotransferases | 2 | 2016 | 2 | 0.060 |
Why?
| | Guanidinoacetate N-Methyltransferase | 2 | 2016 | 5 | 0.060 |
Why?
| | S-Adenosylhomocysteine | 2 | 2016 | 24 | 0.060 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 100 | 0.060 |
Why?
| | DNA Replication | 1 | 1987 | 202 | 0.060 |
Why?
| | Bone Marrow | 1 | 2007 | 244 | 0.060 |
Why?
| | Feces | 2 | 2020 | 373 | 0.060 |
Why?
| | Aged | 6 | 2023 | 19074 | 0.060 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 15 | 0.060 |
Why?
| | Sequence Analysis, RNA | 2 | 2018 | 386 | 0.060 |
Why?
| | S-Adenosylmethionine | 2 | 2016 | 54 | 0.060 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 168 | 0.060 |
Why?
| | Chronic Disease | 1 | 2011 | 1578 | 0.060 |
Why?
| | Diabetes Mellitus | 2 | 2018 | 900 | 0.060 |
Why?
| | Perilipin-1 | 2 | 2019 | 16 | 0.060 |
Why?
| | Adenoma | 1 | 2007 | 189 | 0.060 |
Why?
| | Transcription Factors | 3 | 2019 | 1528 | 0.060 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 448 | 0.060 |
Why?
| | Homocysteine | 2 | 2016 | 136 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2018 | 588 | 0.060 |
Why?
| | Edema | 2 | 2017 | 119 | 0.060 |
Why?
| | Rats, Wistar | 2 | 2016 | 368 | 0.060 |
Why?
| | Tamoxifen | 2 | 2020 | 191 | 0.060 |
Why?
| | Polymerase Chain Reaction | 2 | 1998 | 993 | 0.060 |
Why?
| | Cyclic GMP | 2 | 2019 | 80 | 0.060 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1518 | 0.060 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 73 | 0.060 |
Why?
| | Poly Adenosine Diphosphate Ribose | 1 | 2023 | 2 | 0.060 |
Why?
| | Time Factors | 5 | 2015 | 6116 | 0.060 |
Why?
| | Cyclooxygenase 2 | 2 | 2015 | 164 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2023 | 30 | 0.060 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 348 | 0.060 |
Why?
| | Mammary Glands, Human | 2 | 2016 | 60 | 0.060 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 13 | 0.050 |
Why?
| | Genes, Regulator | 1 | 2023 | 34 | 0.050 |
Why?
| | Acute-Phase Reaction | 1 | 2023 | 39 | 0.050 |
Why?
| | Furosemide | 1 | 2023 | 32 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 351 | 0.050 |
Why?
| | Lipocalin-2 | 1 | 2023 | 61 | 0.050 |
Why?
| | NF-kappa B p50 Subunit | 1 | 2023 | 25 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 47 | 0.050 |
Why?
| | Cell Survival | 4 | 2014 | 1021 | 0.050 |
Why?
| | Antigens, CD | 2 | 2005 | 442 | 0.050 |
Why?
| | Sequence Deletion | 1 | 2003 | 167 | 0.050 |
Why?
| | Interferons | 1 | 2023 | 151 | 0.050 |
Why?
| | Chemokine CCL7 | 1 | 2022 | 2 | 0.050 |
Why?
| | Buthionine Sulfoximine | 1 | 2022 | 7 | 0.050 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 17 | 0.050 |
Why?
| | Benzimidazoles | 1 | 2023 | 138 | 0.050 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 176 | 0.050 |
Why?
| | Cervix Uteri | 1 | 2002 | 45 | 0.050 |
Why?
| | Rats, Inbred F344 | 2 | 1992 | 241 | 0.050 |
Why?
| | Fluorine | 2 | 1992 | 15 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 1842 | 0.050 |
Why?
| | Adenovirus E1A Proteins | 1 | 2001 | 11 | 0.050 |
Why?
| | Sterols | 1 | 2021 | 17 | 0.050 |
Why?
| | Homeostasis | 2 | 2016 | 573 | 0.050 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.050 |
Why?
| | Adenoviruses, Human | 1 | 2001 | 24 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 353 | 0.050 |
Why?
| | Dysbiosis | 1 | 2023 | 146 | 0.050 |
Why?
| | Sodium Glutamate | 1 | 2021 | 7 | 0.050 |
Why?
| | Immune Sera | 2 | 1992 | 79 | 0.050 |
Why?
| | Heme | 1 | 2021 | 52 | 0.050 |
Why?
| | Systems Analysis | 1 | 2021 | 21 | 0.050 |
Why?
| | Intestinal Diseases | 1 | 2021 | 33 | 0.050 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2023 | 144 | 0.050 |
Why?
| | PAX6 Transcription Factor | 1 | 2021 | 18 | 0.050 |
Why?
| | I-kappa B Proteins | 1 | 2022 | 79 | 0.050 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2002 | 100 | 0.050 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 73 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 60 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 88 | 0.050 |
Why?
| | Bilirubin | 1 | 2021 | 88 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 50 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 94 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1131 | 0.050 |
Why?
| | B7-H1 Antigen | 1 | 2022 | 139 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 124 | 0.050 |
Why?
| | Cation Exchange Resins | 1 | 2001 | 7 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2001 | 80 | 0.050 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2022 | 120 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 128 | 0.050 |
Why?
| | Polylysine | 1 | 2001 | 17 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 40 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 172 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1314 | 0.050 |
Why?
| | Drinking | 1 | 2021 | 33 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2023 | 362 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2001 | 99 | 0.050 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 133 | 0.050 |
Why?
| | Plant Oils | 1 | 2000 | 26 | 0.050 |
Why?
| | Calcium | 1 | 2006 | 1108 | 0.050 |
Why?
| | Intestine, Large | 1 | 2020 | 13 | 0.050 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 20 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 33 | 0.040 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 2711 | 0.040 |
Why?
| | Proteostasis | 1 | 2020 | 20 | 0.040 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2020 | 14 | 0.040 |
Why?
| | Fluorescence | 1 | 2001 | 148 | 0.040 |
Why?
| | Receptors, Purinergic P2X3 | 1 | 2020 | 14 | 0.040 |
Why?
| | Dextran Sulfate | 1 | 2020 | 70 | 0.040 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.040 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.040 |
Why?
| | Morphogenesis | 1 | 2021 | 159 | 0.040 |
Why?
| | Leukocytes | 1 | 2022 | 276 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 170 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 301 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 167 | 0.040 |
Why?
| | Feeding Behavior | 2 | 2018 | 574 | 0.040 |
Why?
| | Permeability | 1 | 2020 | 149 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 24 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2023 | 604 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 81 | 0.040 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 50 | 0.040 |
Why?
| | Cytomegalovirus | 1 | 2001 | 144 | 0.040 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 26 | 0.040 |
Why?
| | Ki-67 Antigen | 2 | 2016 | 103 | 0.040 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 18 | 0.040 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 167 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 105 | 0.040 |
Why?
| | Binding Sites | 1 | 2003 | 1168 | 0.040 |
Why?
| | Polymers | 2 | 2014 | 448 | 0.040 |
Why?
| | Purines | 1 | 2020 | 159 | 0.040 |
Why?
| | Thiophenes | 1 | 2020 | 108 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2020 | 148 | 0.040 |
Why?
| | Interleukin-1beta | 1 | 2021 | 370 | 0.040 |
Why?
| | Protein Binding | 3 | 2011 | 1890 | 0.040 |
Why?
| | Interferon-alpha | 1 | 2020 | 186 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 108 | 0.040 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 15 | 0.040 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2002 | 216 | 0.040 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 27 | 0.040 |
Why?
| | Food Preferences | 1 | 2020 | 108 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 104 | 0.040 |
Why?
| | Breast Neoplasms | 1 | 2010 | 1862 | 0.040 |
Why?
| | Cyclin D1 | 1 | 2019 | 61 | 0.040 |
Why?
| | Photoperiod | 1 | 2019 | 48 | 0.040 |
Why?
| | Leishmania donovani | 1 | 2018 | 3 | 0.040 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 951 | 0.040 |
Why?
| | Parasite Load | 1 | 2018 | 7 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2003 | 666 | 0.040 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 189 | 0.040 |
Why?
| | Sirtuins | 1 | 2019 | 32 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 219 | 0.040 |
Why?
| | gamma Catenin | 1 | 2018 | 17 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 88 | 0.040 |
Why?
| | Desmoglein 3 | 1 | 2018 | 17 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 54 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 148 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 171 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 38 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 52 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 75 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 63 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 395 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 74 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 84 | 0.040 |
Why?
| | Inhibitor of Apoptosis Proteins | 3 | 2003 | 42 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 699 | 0.040 |
Why?
| | Adiponectin | 2 | 2013 | 213 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 17 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 100 | 0.040 |
Why?
| | Virulence | 1 | 2018 | 227 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 219 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 25 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 362 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 174 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2003 | 728 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2017 | 58 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 61 | 0.040 |
Why?
| | Models, Molecular | 2 | 2013 | 1369 | 0.040 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 1 | 0.040 |
Why?
| | Urinalysis | 1 | 2017 | 64 | 0.040 |
Why?
| | Bacteria | 1 | 2023 | 725 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.040 |
Why?
| | Isoenzymes | 1 | 2018 | 283 | 0.040 |
Why?
| | Podocytes | 1 | 2017 | 44 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 430 | 0.040 |
Why?
| | DNA | 5 | 1986 | 1352 | 0.030 |
Why?
| | Blood Glucose | 2 | 2018 | 1829 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 155 | 0.030 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| | Immunoenzyme Techniques | 2 | 2011 | 192 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 162 | 0.030 |
Why?
| | Erythema | 1 | 2017 | 25 | 0.030 |
Why?
| | Staining and Labeling | 2 | 1992 | 134 | 0.030 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 463 | 0.030 |
Why?
| | Bronchi | 1 | 2018 | 232 | 0.030 |
Why?
| | Indomethacin | 2 | 2006 | 70 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 164 | 0.030 |
Why?
| | Butyrophilins | 1 | 2016 | 5 | 0.030 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 345 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2019 | 477 | 0.030 |
Why?
| | Neutrophils | 1 | 2022 | 1176 | 0.030 |
Why?
| | Intracellular Membranes | 1 | 2016 | 73 | 0.030 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1996 | 4 | 0.030 |
Why?
| | Okadaic Acid | 1 | 1996 | 11 | 0.030 |
Why?
| | Hybrid Cells | 1 | 1996 | 49 | 0.030 |
Why?
| | Aspartate Aminotransferases | 1 | 2016 | 86 | 0.030 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2016 | 92 | 0.030 |
Why?
| | Connective Tissue | 1 | 2016 | 36 | 0.030 |
Why?
| | Metabolome | 1 | 2019 | 282 | 0.030 |
Why?
| | Survival Rate | 1 | 2020 | 1644 | 0.030 |
Why?
| | Recurrence | 1 | 2019 | 935 | 0.030 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1996 | 152 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 778 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 797 | 0.030 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 48 | 0.030 |
Why?
| | Lentivirus | 1 | 2016 | 45 | 0.030 |
Why?
| | Golgi Apparatus | 1 | 1996 | 89 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 54 | 0.030 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 84 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1760 | 0.030 |
Why?
| | Glucose Intolerance | 1 | 2016 | 136 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 206 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1737 | 0.030 |
Why?
| | Deoxyguanosine | 1 | 2015 | 26 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2017 | 293 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 487 | 0.030 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 41 | 0.030 |
Why?
| | Catalysis | 1 | 2016 | 289 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 259 | 0.030 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 25 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 608 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1036 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1083 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 551 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 4 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 23 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 338 | 0.030 |
Why?
| | Comet Assay | 1 | 2014 | 18 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 560 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 352 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 23 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 81 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 37 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 314 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 293 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 133 | 0.030 |
Why?
| | Kinetics | 3 | 1987 | 1551 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 89 | 0.030 |
Why?
| | Progesterone | 2 | 1987 | 232 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 433 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2013 | 49 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2016 | 378 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 119 | 0.030 |
Why?
| | Computational Biology | 1 | 2017 | 530 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1996 | 723 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 726 | 0.030 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 81 | 0.030 |
Why?
| | Tetraspanin 28 | 2 | 2005 | 4 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2014 | 119 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 66 | 0.030 |
Why?
| | Cell Nucleus | 2 | 2009 | 554 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1992 | 193 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1996 | 669 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 63 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 24 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5047 | 0.030 |
Why?
| | Ketone Bodies | 1 | 2013 | 15 | 0.030 |
Why?
| | Leydig Cells | 1 | 1992 | 11 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 485 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 24 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 63 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4411 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2016 | 460 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1481 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2016 | 530 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1715 | 0.030 |
Why?
| | Theca Cells | 1 | 1992 | 1 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1993 | 176 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 371 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 452 | 0.030 |
Why?
| | Actins | 1 | 2014 | 381 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3330 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 542 | 0.030 |
Why?
| | Models, Chemical | 1 | 2014 | 248 | 0.030 |
Why?
| | Models, Biological | 2 | 2011 | 1621 | 0.030 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 24 | 0.020 |
Why?
| | Insulin | 2 | 2016 | 2080 | 0.020 |
Why?
| | Amino Acids | 1 | 2015 | 448 | 0.020 |
Why?
| | Caseins | 1 | 2011 | 19 | 0.020 |
Why?
| | Palmitic Acid | 1 | 2011 | 36 | 0.020 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 470 | 0.020 |
Why?
| | Survival Analysis | 1 | 2014 | 1211 | 0.020 |
Why?
| | Body Temperature | 1 | 2012 | 208 | 0.020 |
Why?
| | Serum Albumin | 1 | 2012 | 137 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2013 | 785 | 0.020 |
Why?
| | Lipase | 1 | 2011 | 55 | 0.020 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 1879 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1538 | 0.020 |
Why?
| | Retinal Dehydrogenase | 1 | 2011 | 33 | 0.020 |
Why?
| | Membranes, Artificial | 1 | 2011 | 65 | 0.020 |
Why?
| | Tritium | 1 | 1990 | 66 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 958 | 0.020 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 80 | 0.020 |
Why?
| | Cations, Divalent | 1 | 1990 | 51 | 0.020 |
Why?
| | Baculoviridae | 1 | 2010 | 44 | 0.020 |
Why?
| | Mitochondria, Liver | 1 | 2010 | 67 | 0.020 |
Why?
| | Histones | 1 | 2015 | 535 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 135 | 0.020 |
Why?
| | Insecta | 1 | 2010 | 64 | 0.020 |
Why?
| | NAD | 1 | 2010 | 63 | 0.020 |
Why?
| | Hydrolysis | 1 | 1990 | 173 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 134 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 323 | 0.020 |
Why?
| | Seasons | 1 | 2012 | 442 | 0.020 |
Why?
| | Oxidants | 1 | 2010 | 112 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 208 | 0.020 |
Why?
| | Transgenes | 1 | 2010 | 170 | 0.020 |
Why?
| | HeLa Cells | 2 | 2001 | 562 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 28 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1990 | 97 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 641 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 105 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1016 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 343 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2009 | 67 | 0.020 |
Why?
| | Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 49 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1473 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 591 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2008 | 96 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 138 | 0.020 |
Why?
| | Administration, Oral | 1 | 2010 | 728 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 432 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 335 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1644 | 0.020 |
Why?
| | Cell Movement | 2 | 2009 | 869 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 523 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 16 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 271 | 0.020 |
Why?
| | Reflex, Stretch | 1 | 2006 | 9 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6347 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 53 | 0.020 |
Why?
| | Infant | 1 | 2019 | 7964 | 0.020 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 3 | 0.020 |
Why?
| | Vanadium | 1 | 1986 | 4 | 0.020 |
Why?
| | Vanadates | 1 | 1986 | 13 | 0.020 |
Why?
| | Carbachol | 1 | 1986 | 21 | 0.020 |
Why?
| | Prostaglandins E | 1 | 1986 | 44 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 323 | 0.020 |
Why?
| | Thymidine | 1 | 1986 | 58 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1986 | 44 | 0.020 |
Why?
| | Growth Substances | 1 | 1986 | 138 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 352 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2009 | 520 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1986 | 82 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1226 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 182 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 1986 | 161 | 0.020 |
Why?
| | Tetraspanins | 1 | 2005 | 15 | 0.020 |
Why?
| | Dinoprostone | 1 | 1986 | 184 | 0.020 |
Why?
| | Detergents | 1 | 2005 | 41 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1986 | 227 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 104 | 0.020 |
Why?
| | Uteroglobin | 2 | 1984 | 16 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1987 | 267 | 0.020 |
Why?
| | Solubility | 1 | 2005 | 223 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 9119 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2087 | 0.010 |
Why?
| | Introns | 1 | 2005 | 227 | 0.010 |
Why?
| | Multiprotein Complexes | 1 | 2005 | 140 | 0.010 |
Why?
| | Metformin | 1 | 2007 | 276 | 0.010 |
Why?
| | Testosterone | 1 | 1987 | 343 | 0.010 |
Why?
| | Glucagon | 1 | 2003 | 92 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1618 | 0.010 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2005 | 196 | 0.010 |
Why?
| | Fibroblasts | 1 | 2007 | 838 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 2 | 1979 | 157 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 43 | 0.010 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2002 | 42 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 292 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2002 | 101 | 0.010 |
Why?
| | Mucous Membrane | 1 | 2002 | 108 | 0.010 |
Why?
| | Photochemistry | 2 | 1992 | 125 | 0.010 |
Why?
| | Sheep | 3 | 1992 | 764 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1979 | 301 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2000 | 32 | 0.010 |
Why?
| | Gestational Age | 1 | 2003 | 760 | 0.010 |
Why?
| | Molecular Structure | 2 | 1992 | 434 | 0.010 |
Why?
| | Polyribosomes | 1 | 1980 | 22 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 163 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 200 | 0.010 |
Why?
| | Keratins | 1 | 2001 | 176 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17855 | 0.010 |
Why?
| | DNA, Viral | 1 | 2002 | 350 | 0.010 |
Why?
| | Thyrotropin | 1 | 1980 | 99 | 0.010 |
Why?
| | Thyroid Gland | 1 | 1980 | 82 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1979 | 23 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1013 | 0.010 |
Why?
| | Child | 1 | 2018 | 18422 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 700 | 0.010 |
Why?
| | Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
| | Papillomavirus Infections | 1 | 2002 | 261 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1978 | 253 | 0.010 |
Why?
| | Cell Cycle | 1 | 1978 | 542 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2000 | 561 | 0.010 |
Why?
| | RNA | 1 | 1980 | 809 | 0.010 |
Why?
| | Luteal Cells | 1 | 1992 | 2 | 0.010 |
Why?
| | Esters | 1 | 1992 | 61 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 38 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 80 | 0.000 |
Why?
| | Estrogen Antagonists | 1 | 1984 | 39 | 0.000 |
Why?
| | Poly A | 1 | 1980 | 46 | 0.000 |
Why?
| | RNA, Ribosomal | 1 | 1980 | 157 | 0.000 |
Why?
| | Fixatives | 1 | 1978 | 15 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1978 | 27 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1978 | 173 | 0.000 |
Why?
| | Cricetinae | 1 | 1978 | 253 | 0.000 |
Why?
| | Magnesium | 1 | 1978 | 145 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1978 | 511 | 0.000 |
Why?
|
|
Orlicky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|